GGrantIndex
← Search

PHASE II STUDY OF INTERMITTENT RECOMBINANT HUMAN INTERLEUKIN-2 BY INTRAVENOUSLY

$207,266M01FY2001RRNIH

University Of California Los Angeles, Los Angeles CA

Investigators

Linked publications & trials

View original record on NIH RePORTER →